Article: 14-Alkoxy- and 14-Acyloxypyridomorphinans: μ Agonist/δ Antagonist Opioid Analgesics with Diminished Tolerance and Dependence Side Effects.20Views0Downloads1Citation
Article: 6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists.25Views0Downloads0Citations
Dr. Edward Bilsky currently serves as the Vice President for Research and Scholarship at the University of New England. His laboratory conducts translational research in the areas of pain, addiction and other neurological disorders. He has received over 5 million dollars in extramural funding through a variety of federal, state and private grants and contracts and has published over 70 peer-reviewed publications.